Ohio State University Comprehensive Cancer Center

18 results found.

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer, S Clinical Trial using propranolol hydrochloride; Correlative Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Pilot Study of Beta-Blockers in Patients With Advanced Cancer.
propranolol hydrochloride; Correlative Studies

Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Sta Clinical Trial using MOR00208; lenalidomide; Correlative Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years to 80 years.
- A Phase II Study of MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)Prolymphocytic Leukemia (PLL) or Patients With Untreated CLL/SLL/PLL.
MOR00208; lenalidomide; Correlative Studies

B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cance Clinical Trial using carfilzomib; Cytokine Assessment; Pharmacodynamic Studies; Proteosome Inhibition Assessment; Pharmacogenomic Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)/Prolymphocytic Leukemia (PLL).
carfilzomib; Cytokine Assessment; Pharmacodynamic Studies; Proteosome Inhibition Assessment; Pharmacogenomic Studies

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Pre Clinical Trial using panobinostat; lenalidomide

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma.
panobinostat; lenalidomide

Eye Cancer Clinical Trial using dynamic contrast-enhanced magnetic resonance imaging

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- Dynamic Contrast Enhanced Magnetic Resonance Imaging for Non-Invasive Diagnostic Work-Up in Solid Tumors of the Eye and Orbit..
dynamic contrast-enhanced magnetic resonance imaging

Bone Metastases, Musculoskeletal Cancer, Soft Tissue Sarcoma, or Clinical Trial using acetylsalicylic acid; enoxaparin; thromboembolism prophylaxis

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology.
acetylsalicylic acid; enoxaparin; thromboembolism prophylaxis

Healthy, or Human Papilloma Virus Infection Clinical Trial using educational intervention; questionnaire administration

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- The Ohio State University Center for Population Health and Health Disparities Community Awareness, Resources and Education (CARE II): Project 4 The PARENT (Parents in Appalachia Receive Education Needed for Teens) Project.
educational intervention; questionnaire administration

Anxiety Disorder, Worry, Uncertainty, Sleep Disorders, Insomnia, Clinical Trial using Cognitive-behavioral therapy for worry, uncertainty & insomnia

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors.
Cognitive-behavioral therapy for worry, uncertainty & insomnia

Stage III Squamous Cell Carcinoma of the Oropharynx, or Stage IV Clinical Trial using vorinostat; cisplatin; radiation therapy; Correlative Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I Trial Of Vorinostat In The Treatment Of Advanced Laryngeal, Hypopharyngeal, Nasopahryngeal And Oropharyngeal Squamous Cell Carcinoma Of The Head And Neck..
vorinostat; cisplatin; radiation therapy; Correlative Studies

Breast Cancer Clinical Trial using ultrasound imaging

Ohio State University Comprehensive Cancer Center - Recruiting 55 years or older.
- Lymph Node Evaluation in the Axilla of Symptomatic Older Women During Breast Sonography..
ultrasound imaging

Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of Clinical Trial using panitumumab; irinotecan hydrochloride; fluorouracil; leucovorin calcium

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Panitumumab in Combination With FOLFIRI After Progression on FOLFIRI Plus Bevacizumab in KRAS(Kirsten Rat Sarcoma) Wild-Type Metastatic Colorectal Cancer..
panitumumab; irinotecan hydrochloride; fluorouracil; leucovorin calcium

Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucou Clinical Trial using fluorescence imaging; biopsy; examination; Comparison of surgical margins by COE vs. DVFE

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- The Role of Direct Visual Fluorescence in Oral Examination.
fluorescence imaging; biopsy; examination; Comparison of surgical margins by COE vs. DVFE

Glioblastoma Multiforme/Anaplastic Astrocytoma Clinical Trial using temozolomide; radiation therapy; stereotactic radiotherapy

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I Trial of Hypofraction Radiotherapy + Temozolomide in the Treatment of Patients With Glioblastoma Multiforme and Anaplastic Astrocytoma of the Brain.
temozolomide; radiation therapy; stereotactic radiotherapy

Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial using dabrafenib; pazopanib hydrochloride; Correlative studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I Trial of Dabrafenib (BRAFi) and Pazopanib in Patients With BRAF-mutated Advanced Malignant Tumors.
dabrafenib; pazopanib hydrochloride; Correlative studies

Follicular Thyroid Cancer, Insular Thyroid Cancer, Papillary Thyr Clinical Trial using dabrafenib; trametinib; Correlative Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma.
dabrafenib; trametinib; Correlative Studies

Bladder Cancer Clinical Trial using Sample Collection

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- Biomarker Identification for Bladder Cancer Patients.
Sample Collection

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using yttrium Y 90 glass microspheres; laboratory biomarker analysis

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Humanitarian Device Exemption Treatment Protocol of TheraSpherer For Treatment of Unresectable Hepatocellular Carcinoma.
yttrium Y 90 glass microspheres; laboratory biomarker analysis

Multiple Myeloma Clinical Trial using lenalidomide; pidilizumab; pharmacological study; laboratory biomarker analysis

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- Phase I/II Study of Lenalidomide in Combination With Anti-PD-1 Monoclonal Antibody CT-011 in Patients With Relapsed/Refractory Multiple Myeloma.
lenalidomide; pidilizumab; pharmacological study; laboratory biomarker analysis